Collectively, our results showed that optimized design of RT-RPA primers and Cas12a crRNA could enable specific detection of IAVs and IBVs, which was necessary for instructing subsequent clinical treatment particularly considering the occurrence of co-infection of SARS-CoV-2 and influenza viruses (Ozaras et al., 2020). This evidence concerns the gene RPA1 and coinfection.